Shield Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Shield Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 193% to $13,085,000. The net income raised on -$33,293,000 and profit margin reached -254%. Total operating expenses were $35,358,000.
Profit Margin
| 2014 | 0 | -12.90M | |
|---|---|---|---|
| 2015 | 0 | -23.62M | |
| 2016 | 304K | -15.01M | -4939.47% |
| 2017 | 637K | -19.58M | -3075.04% |
| 2018 | 11.88M | -1.79M | -15.1% |
| 2019 | 719K | -8.8M | -1223.92% |
| 2020 | 10.38M | -2.63M | -25.32% |
| 2021 | 1.51M | -19.33M | -1272.94% |
| 2022 | 4.46M | -40.44M | -905.4% |
| 2023 | 13.08M | -33.29M | -254.44% |
STX.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 13.08M | 4.46M | 1.51M | 10.38M | 719K | 11.88M | 637K | 304K | 0 | 0 |
Cost of revenue | 9.05M | 2.47M | 980K | 1.35M | 485K | 311K | 155K | 100K | 50K | 0 |
Gross profit | 4.02M | 1.99M | 539K | 9.03M | 234K | 11.57M | 482K | 204K | -50K | 0 |
Operating exp. | ||||||||||
Research and development | 1.81M | 1.07M | 579K | 2.57M | 2.49M | 4.3M | 4.71M | 2.02M | 5.28M | 2.66M |
Selling and marketing | 21.71M | 16.00M | 10.26M | 281K | 59K | 3.49M | 9.13M | 4.17M | 0 | 0 |
Total operating expenses | 35.35M | 27.70M | 20.49M | 11.18M | 9.26M | 16.73M | 21.43M | 12.66M | 6.43M | 3.39M |
Operating income | -31.33M | -25.70M | -19.95M | -1.88M | -9.03M | -5.16M | -20.95M | -12.46M | -6.43M | -3.39M |
Other income (expenses), net | 5.28M | -14.37M | 387K | 0 | -31K | 15K | -43K | -3.14M | -18.05M | -10.03M |
Income before tax | -26.04M | -40.08M | -19.56M | -1.88M | -9.06M | -5.15M | -20.99M | -15.60M | -24.48M | -13.43M |
Income tax expense | 918K | 362K | -229K | 744K | -266K | -3.35M | -1.40M | -587K | -861K | -525K |
Net income | -33.29M | -40.44M | -19.33M | -2.63M | -8.8M | -1.79M | -19.58M | -15.01M | -23.62M | -12.90M |
Earnings per share | ||||||||||
Basic EPS | -0.03 | -0.17 | -0.09 | -0.02 | -0.07 | -0.01 | -0.17 | -0.14 | -0.55 | -0.39 |
Diluted EPS | -0.03 | -0.17 | -0.09 | -0.02 | -0.07 | -0.01 | -0.17 | -0.14 | -0.55 | -0.39 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |